|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-5-22
|
|
pubmed:abstractText |
The Heart Outcomes Prevention Evaluation (HOPE) trial demonstrated that ischemic events are decreased in patients receiving angiotensin-converting enzyme (ACE) inhibitors. This study sought to determine whether pretreatment with ACE inhibitors would attentuate ischemic injury during surgical revascularization of ischemic myocardium.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0003-4975
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1522-7
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12022543-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:12022543-Animals,
pubmed-meshheading:12022543-Coronary Circulation,
pubmed-meshheading:12022543-Electrocardiography,
pubmed-meshheading:12022543-Hemodynamics,
pubmed-meshheading:12022543-Isoquinolines,
pubmed-meshheading:12022543-Myocardial Reperfusion Injury,
pubmed-meshheading:12022543-Premedication,
pubmed-meshheading:12022543-Swine,
pubmed-meshheading:12022543-Tetrahydroisoquinolines,
pubmed-meshheading:12022543-Treatment Outcome,
pubmed-meshheading:12022543-Ventricular Fibrillation
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Pretreatment with angiotensin-converting enzyme inhibitors attenuates ischemia-reperfusion injury.
|
|
pubmed:affiliation |
Department of Cardiothoracic Surgery, Boston Medical Center, Massachusetts 02118, USA. harold.lazar@bmc.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
